The illness often mistaken for the common cold is making a comeback this fall as numbers have been historically lower following COVID-19 and the precautions ... adults and older children, RSV ...

We all know the vital precautions to keep babies safe from respiratory syncytial virus (RSV). While the virus is the leading cause of infant hospitalization nationwide, it can also impact adults ...

As the chill of winter approaches, most of us are well-versed in the annual warnings about the flu and, more recently, ...

The signs might be apparent in adults - but less noticeable in young infants. While RSV typically causes a mild, cold-like illness, it can also lead to severe illness such as bronchiolitis and ...

This led to lower-than-expected RSV cases, as older adults adhered to COVID-19 precautions such as reduced social interactions and mask-wearing. Consequently, while the trials met efficacy end ...

To stay healthy, people at high risk and their loved ones should take precautions — whether ... are at a higher risk for severe RSV. Additionally, older adults who are 60 to 74 and live in ...

As you dive into your New Year’s resolutions, taking precautions to protect ... get that flu shot.” An RSV vaccine is also ...

It also estimates that there are anywhere from 2.1 million non-hospitalization visits among children younger than 5 years old for RSV and 100,000–160,000 hospitalizations among adults 60 years ...

Other precautions include hand washing ... including those who are pregnant. DOH recommends RSV vaccines for older adults and those who are pregnant. The Kitsap Public Health District has schedule ...

Among adults with outpatient respiratory syncytial virus (RSV) infections across six RSV seasons, roughly one in 20 were hospitalized within 28 days, according to a large cohort study that used ...

These precautions are being taken to keep patients ... young children, and older adults from RSV.

Two other companies – Pfizer and Moderna – also manufacture RSV vaccines approved for adults 60 and older, and are testing their shots in younger adults. Pfizer told investors last month it ...